Pang, Hong-Bo
Braun, Gary B.
Friman, Tomas
Aza-Blanc, Pedro
Ruidiaz, Manuel E.
Sugahara, Kazuki N.
Teesalu, Tambet
Ruoslahti, Erkki
Article History
Received: 18 April 2014
Accepted: 2 August 2014
First Online: 3 October 2014
Competing interests
: K.N.S., T.T. and E.R. have ownership interest (including patents) in CendR Therapeutics Inc. E.R. is the founder, chairman of the board, consultant/advisory board member and major shareholder of CendR Therapeutics Inc., and has ownership interest (including patents) in the same. ER is also a consultant/advisory board member, and a major shareholder of EnduRx Pharmaceuticals Inc. and has ownership interest (including patents) in the same. No potential conflicts of interest were disclosed by the other authors.